Journal
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
Volume 10, Issue 2, Pages 84-92Publisher
WILEY
DOI: 10.1111/cts.12455
Keywords
-
Categories
Ask authors/readers for more resources
US Food and Drug Administration (FDA)-approved diagnostic assays play an increasingly common role in managing patients to prolong lifespan while also enhancing quality of life. Diagnostic assays can be essential for the safe and effective use of therapeutics (companion diagnostic), or may inform on improving the benefit/risk ratio without restricting drug access (complementary diagnostic). This tutorial reviews strategic considerations for drug and assay development resulting in FDA-approved companion or complementary diagnostic status.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available